Clinical Trials for Pituitary conditions

Clinical trials are research studies conducted in an effort to improve overall patient health and care. Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition. Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks. A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.

A brief description of each phase:

• Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
• Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
• Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
• Phase IV: These studies monitor long-term side effects after the treatment has been marketed.

Clinical Trials data for Pituitary conditions is grouped into the following categories:-

• View by trial name
• View by drugs used in Pituitary conditions clinical trials

Clinical Trials by trial name

The format for each of the following is:

• The name of the trial,
• followed by whether the trial is recruiting patients,
  - The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
  - Note**: Please follow the link to determine the current trial status.
• followed by a list of drug/s, if any, used in the trial

ClinicalTrials.gov has listed the following trials for Pituitary conditions:

• Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities - This study is currently recruiting patients (Current: 23 Nov 2006) - TRH (Thyrotropin Releasing Hormone)
• Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq - This study is currently recruiting patients (Current: 23 Nov 2006) - Somatropin (rDNA origin)
• Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency - This study is currently recruiting patients (Current: 23 Nov 2006) - Genotropin
• Treatment of Adults With Growth Hormone Deficiency - This study is currently recruiting patients (Current: 23 Nov 2006) - growth hormone
• Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women - This study is no longer recruiting patients (Current: 23 Nov 2006) - Genotropin
• Evaluation of Patients With Thyroid Disorders - This study is currently recruiting patients (Current: 23 Nov 2006)
• Evaluation of Factors in Human Brain Tumors - This study has been completed (Current: 23 Nov 2006)
• Genetic Investigation of Pediatric Tumors of the Pituitary Gland - This study is currently recruiting patients (Current: 23 Nov 2006)
• Sandostatin LAR Depot Vs. Surgery for Treating Acromegaly - This study has been completed (Current: 23 Nov 2006)
• The Treatment and Natural History of Acromegaly - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy - This study is currently recruiting patients (Current: 23 Nov 2006) - antineoplaston A10,antineoplaston AS2-1
• Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly - This study has been completed (Current: 23 Nov 2006)
• Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus - This study has been completed (Current: 23 Nov 2006) - chlorothiazide
• Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus - This study has been completed (Current: 23 Nov 2006) - chlorpropamide,desmopressin
• Study of Novel Types of Familial Diabetes Insipidus - This study is no longer recruiting patients (Current: 23 Nov 2006) - desmopressin
• Study of Pituitary Size and Function in Familial Dwarfism of Sindh - This study has been completed (Current: 23 Nov 2006)
• Measurement of Outcome of Surgical Treatment in Patients With Acromegaly - This study is currently recruiting patients (Current: 23 Nov 2006)
• Randomized Study of Growth Hormone on Bone Mineral Density in Patients With Adult Onset Growth Hormone Deficiency - This study has been completed (Current: 23 Nov 2006) - growth hormone
• Androgen Replacement Therapy in Women With Hypopituitarism - This study is currently recruiting patients (Current: 23 Nov 2006) - TheraDerm
• Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) - This study has been completed (Current: 23 Nov 2006) - Vasopressin receptor antagonist
• Pegvisomant And Sandostatin LAR Combination Study - This study is no longer recruiting patients (Current: 23 Nov 2006) - Pegvisomant/ Sandostatin LAR,Sandostatin LAR,Pegvisomant
• A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly - This study is no longer recruiting patients (Current: 23 Nov 2006) - Pegvisomant,Sandostatin LAR
• SALT Trial Study of Ascending Levels of Tolvaptan in Hyponatremia - This study has been completed (Current: 23 Nov 2006) - tolvaptan
• Testosterone and Growth Hormone for Bone Loss in Men - This study is currently recruiting patients (Current: 23 Nov 2006) - Testosterone, human growth hormone
• Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients - This study is no longer recruiting patients (Current: 23 Nov 2006) - SOM230 s.c.,Sandostatin s.c
• National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Role of Nutrition and Hormones in Boys With Disordered Growth - This study is currently recruiting patients (Current: 23 Nov 2006) - Growth Hormone Therapy
• Somatropin (Norditropin) in Insulin-Like Growth Factor (IGF) Deficient Children - This study is no longer recruiting patients (Current: 23 Nov 2006) - Somatropin (Norditropin®)
• Cool.Click Adolescent Transition Study: Study of Saizen in Subjects With Childhood-Onset Growth Hormone Deficiency - This study is no longer recruiting patients (Current: 23 Nov 2006) - Saizen®
• Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Nave Acromegalic Patients - This study has been completed (Current: 23 Nov 2006) - Octreotide LAR
• Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys - This study is no longer recruiting patients (Current: 23 Nov 2006) - Arimidex (Anastrozole)
• Growth Hormone and Chromosome 18q- and Abnormal Growth - This study is no longer recruiting patients (Current: 23 Nov 2006) - Nutropin AQ
• Ghrelin, GH and Cortisol Interaction in GHD Patients - This study is currently recruiting patients (Current: 23 Nov 2006) - Human acylated ghrelin
• Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia - This study is currently recruiting patients (Current: 23 Nov 2006) - Nutropin AQ
• Long Term Study With B2036-PEG - This study is no longer recruiting patients (Current: 23 Nov 2006) - Pegvisomant
• Testosterone Gel Applied to Women With Pituitary Gland Problems - This study is currently recruiting patients (Current: 23 Nov 2006) - Testosterone Gel
• Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism - This study is currently recruiting patients (Current: 23 Nov 2006) - Transdermal Testosterone Gel
• Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction - This study has been completed (Current: 23 Nov 2006) - Lanreotide Autogel and Octreotide LAR
• IGF1 Generation Test - This study has been completed (Current: 23 Nov 2006)
• Somatuline Autogel: Acromegaly Self/Partner Injection Study - This study is no longer recruiting patients (Current: 23 Nov 2006) - Lanreotide (Autogel formulation)
• Consequence of Lifetime Isolated Growth Hormone Deficiency - This study is currently recruiting patients (Current: 23 Nov 2006) - growth hormone adminsitration for 6 months
• Canadian Pegvisomant Compassionate Study In Acromegalic Patients - This study is no longer recruiting patients (Current: 23 Nov 2006) - Pegvisomant treatment
• Transition Study - This study has been completed (Current: 23 Nov 2006)
• An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Patients With Acromegaly - This study is no longer recruiting patients (Current: 23 Nov 2006) - Pasireotide
• Octreotide Efficacy and Safety in First-Line Acromegalic Patients - This study has been suspended (Current: 23 Nov 2006) - Octreotide
• Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushings Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Pasireotide
• Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary - This study is currently recruiting patients (Current: 23 Nov 2006) - Somatropin
• Effect of Growth Hormone on Bone Mineral Density in Young Adults With Childhood Onset Growth Hormone Deficiency. - This study is no longer recruiting patients (Current: 23 Nov 2006) - Growth Hormone
• Long-Term Trial on Growth Hormone Deficiency in Adults (GHDA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - Growth Hormone
• Long-Term Trial on Growth Hormone Deficiency in Adults (GHDA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - Growth Hormone
• Growth Hormone Treatment of Young Growth Hormone-Deficient Adults - This study is currently recruiting patients (Current: 23 Nov 2006) - Growth hormone
• Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency - This study is no longer recruiting patients (Current: 23 Nov 2006) - Somatropin
• Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency - This study is no longer recruiting patients (Current: 23 Nov 2006) - Somatropin
• Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 Mg) in Acromegalic Patients - This study has been completed (Current: 23 Nov 2006) - Lanreotide (Autogel formulation)
• Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR - This study is currently recruiting patients (Current: 23 Nov 2006) - Lanreotide (Autogel formulation)
• Use of Somatostatin Analogue Therapy as Primary Medical Treatment of Acromegaly - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Somatuline Autogel
• Safety and Efficacy of Long-Acting Repeatable Octreotide Acetate for Injectable Suspension Vs. Surgery in Treatment-nave Patients With Acromegaly - This study has been completed (Current: 23 Nov 2006) - Octreotide LAR – pituitary surgery
• Chromosome 18 Clinical Research Center - This study is currently recruiting patients (Current: 23 Nov 2006)
• A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide - This study has been completed (Current: 23 Nov 2006)
• Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly - This study has been completed (Current: 23 Nov 2006) - Lanreotide (Autogel formulation)
• The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children. - This study is currently recruiting patients (Current: 23 Nov 2006)
• Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas - This study has been completed (Current: 23 Nov 2006) - Octreotide acetate
• A Phase IV Open-Label Study of Predictive Markers in Growth Hormone Deficient and Turner Syndrome Pre-Pubertal Children Treated With SAIZEN - This study is currently recruiting patients (Current: 23 Nov 2006)
• Effect of Growth Hormone in Children With Growth Hormone Deficiency - This study has been completed (Current: 23 Nov 2006) - Somatropin [rDNA origin] (Norditropin®)
• Constructing an Insulin-Like Growth Factor-Based Prediction Model - This study is currently recruiting patients (Current: 23 Nov 2006)
• Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) - This study is currently recruiting patients (Current: 23 Nov 2006) - SR121463B
• Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion - This study is no longer recruiting patients (Current: 23 Nov 2006) - SR121463B
• Treatment of Children With Insufficient Secretion of Growth Hormone - This study is currently recruiting patients (Current: 23 Nov 2006) - growth hormone (somatropin)
• Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety - This study is currently recruiting patients (Current: 23 Nov 2006) - ALTU-238
• Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-Secretion Caused by Treatment With Antiepileptic Medicine - This study is currently recruiting patients (Current: 23 Nov 2006)
• A Study to Evaluate the Dose Response and Safety of Pha-794428 in Adults With Growth Hormone Deficiency - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - PHA-794428
• A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - PHA-794428
• Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Bromocriptin
• Estrogen Treatment in Acromegalic Women - This study is currently recruiting patients (Current: 23 Nov 2006) - Alesse
• Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation - This study is no longer recruiting patients (Current: 23 Nov 2006) - Thyroxin,Triiodothyronine
• Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency - This study is currently recruiting patients (Current: 23 Nov 2006) - growth hormone (drug)
• Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly - This study is currently recruiting patients (Current: 23 Nov 2006) - Octreotide acetate
• Growth Hormone and Endothelial Function in Children - This study is currently recruiting patients (Current: 23 Nov 2006) - growth hormone
• Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly - This study is currently recruiting patients (Current: 23 Nov 2006) - Octreotide acetate and cabergoline
• Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients - This study is currently recruiting patients (Current: 23 Nov 2006) - lanreotide (Autogel formulation),Pegvisomant
• Growth Hormone's Effect on the Cardiovascular System - This study is currently recruiting patients (Current: 23 Nov 2006) - Growth Hormone

Drugs used in Clinical Trials for Pituitary conditions

The format for each of the following is:

• The drug,
• followed by the name of the trial,
• followed by whether the trial is recruiting patients,
  - The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
  - Note**: Please follow the link to determine the current trial status.

ClinicalTrials.gov has listed the following drugs in trials for Pituitary conditions:

• ALTU-238 - Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alesse - Estrogen Treatment in Acromegalic Women - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston As2-1 - Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy - This study is currently recruiting patients (Current: 23 Nov 2006)
• Arimidex (Anastrozole) - Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bromocriptin - Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Chlorothiazide - Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus - This study has been completed (Current: 23 Nov 2006)
• Chlorpropamide - Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus - This study has been completed (Current: 23 Nov 2006)
• Desmopressin - Study of Novel Types of Familial Diabetes Insipidus - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Desmopressin - Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus - This study has been completed (Current: 23 Nov 2006)
• Genotropin - Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency - This study is currently recruiting patients (Current: 23 Nov 2006)
• Genotropin - Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Growth Hormone (Drug) - Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency - This study is currently recruiting patients (Current: 23 Nov 2006)
• Growth Hormone (Somatropin) - Treatment of Children With Insufficient Secretion of Growth Hormone - This study is currently recruiting patients (Current: 23 Nov 2006)
• Growth Hormone Adminsitration For 6 Months - Consequence of Lifetime Isolated Growth Hormone Deficiency - This study is currently recruiting patients (Current: 23 Nov 2006)
• Growth Hormone Therapy - Role of Nutrition and Hormones in Boys With Disordered Growth - This study is currently recruiting patients (Current: 23 Nov 2006)
• Growth Hormone - Effect of Growth Hormone on Bone Mineral Density in Young Adults With Childhood Onset Growth Hormone Deficiency. - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Growth Hormone - Growth Hormone and Endothelial Function in Children - This study is currently recruiting patients (Current: 23 Nov 2006)
• Growth Hormone - Growth Hormone's Effect on the Cardiovascular System - This study is currently recruiting patients (Current: 23 Nov 2006)
• Growth Hormone - Long-Term Trial on Growth Hormone Deficiency in Adults (GHDA) - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Growth Hormone - Long-Term Trial on Growth Hormone Deficiency in Adults (GHDA) - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Growth Hormone - Randomized Study of Growth Hormone on Bone Mineral Density in Patients With Adult Onset Growth Hormone Deficiency - This study has been completed (Current: 23 Nov 2006)
• Growth Hormone - Treatment of Adults With Growth Hormone Deficiency - This study is currently recruiting patients (Current: 23 Nov 2006)
• Growth hormone - Growth Hormone Treatment of Young Growth Hormone-Deficient Adults - This study is currently recruiting patients (Current: 23 Nov 2006)
• Human acylated ghrelin - Ghrelin, GH and Cortisol Interaction in GHD Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• Lanreotide (Autogel Formulation) - Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• Lanreotide (Autogel formulation) - Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly - This study has been completed (Current: 23 Nov 2006)
• Lanreotide (Autogel formulation) - Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 Mg) in Acromegalic Patients - This study has been completed (Current: 23 Nov 2006)
• Lanreotide (Autogel formulation) - Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR - This study is currently recruiting patients (Current: 23 Nov 2006)
• Lanreotide (Autogel formulation) - Somatuline Autogel: Acromegaly Self/Partner Injection Study - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Lanreotide Autogel and Octreotide LAR - Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction - This study has been completed (Current: 23 Nov 2006)
• Nutropin AQ - Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia - This study is currently recruiting patients (Current: 23 Nov 2006)
• Nutropin AQ - Growth Hormone and Chromosome 18q- and Abnormal Growth - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Octreotide LAR – pituitary surgery - Safety and Efficacy of Long-Acting Repeatable Octreotide Acetate for Injectable Suspension Vs. Surgery in Treatment-nave Patients With Acromegaly - This study has been completed (Current: 23 Nov 2006)
• Octreotide LAR - Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Nave Acromegalic Patients - This study has been completed (Current: 23 Nov 2006)
• Octreotide acetate and cabergoline - Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly - This study is currently recruiting patients (Current: 23 Nov 2006)
• Octreotide acetate - Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly - This study is currently recruiting patients (Current: 23 Nov 2006)
• Octreotide acetate - Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas - This study has been completed (Current: 23 Nov 2006)
• Octreotide - Octreotide Efficacy and Safety in First-Line Acromegalic Patients - This study has been suspended (Current: 23 Nov 2006)
• PHA-794428 - A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• PHA-794428 - A Study to Evaluate the Dose Response and Safety of Pha-794428 in Adults With Growth Hormone Deficiency - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Pasireotide - An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Patients With Acromegaly - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Pasireotide - Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushings Disease - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Pegvisomant treatment - Canadian Pegvisomant Compassionate Study In Acromegalic Patients - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Pegvisomant/ Sandostatin LAR - Pegvisomant And Sandostatin LAR Combination Study - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Pegvisomant - A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Pegvisomant - Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• Pegvisomant - Long Term Study With B2036-PEG - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Pegvisomant - Pegvisomant And Sandostatin LAR Combination Study - This study is no longer recruiting patients (Current: 23 Nov 2006)
• SOM230 s.c. - Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients - This study is no longer recruiting patients (Current: 23 Nov 2006)
• SR121463B - Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion - This study is no longer recruiting patients (Current: 23 Nov 2006)
• SR121463B - Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Saizen® - Cool.Click Adolescent Transition Study: Study of Saizen in Subjects With Childhood-Onset Growth Hormone Deficiency - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Sandostatin LAR - A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Sandostatin LAR - Pegvisomant And Sandostatin LAR Combination Study - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Sandostatin s.c. - Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Somatropin (Norditropin®) - Somatropin (Norditropin) in Insulin-Like Growth Factor (IGF) Deficient Children - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Somatropin (rDNA origin) - Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq - This study is currently recruiting patients (Current: 23 Nov 2006)
• Somatropin [rDNA origin] (Norditropin®) - Effect of Growth Hormone in Children With Growth Hormone Deficiency - This study has been completed (Current: 23 Nov 2006)
• Somatropin - Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Somatropin - Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Somatropin - Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary - This study is currently recruiting patients (Current: 23 Nov 2006)
• Somatuline Autogel - Use of Somatostatin Analogue Therapy as Primary Medical Treatment of Acromegaly - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• TRH (Thyrotropin Releasing Hormone) - Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities - This study is currently recruiting patients (Current: 23 Nov 2006)
• Testosterone Gel - Testosterone Gel Applied to Women With Pituitary Gland Problems - This study is currently recruiting patients (Current: 23 Nov 2006)
• Testosterone, human growth hormone - Testosterone and Growth Hormone for Bone Loss in Men - This study is currently recruiting patients (Current: 23 Nov 2006)
• TheraDerm - Androgen Replacement Therapy in Women With Hypopituitarism - This study is currently recruiting patients (Current: 23 Nov 2006)
• Thyroxin - Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Tolvaptan - SALT Trial Study of Ascending Levels of Tolvaptan in Hyponatremia - This study has been completed (Current: 23 Nov 2006)
• Transdermal Testosterone Gel - Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism - This study is currently recruiting patients (Current: 23 Nov 2006)
• Triiodothyronine - Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Vasopressin receptor antagonist - Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) - This study has been completed (Current: 23 Nov 2006)

The trial data on this page has been sourced from

• The U.S. National Library of Medicine (NLM) together with ClinicalTrials.gov

Search Specialists by State and City